H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials

Lancet. 1977 Mar 19;1(8012):617-9. doi: 10.1016/s0140-6736(77)92055-4.

Abstract

In two controlled trials, involving 75 patients, on the prevention of bleeding from gastric erosions in fulminant hepatic failure, antacids given four-hourly had no significant effect. Only 35% of intragastric pH recordings taken at two-hourly intervals in the treated group were maintained above 5 with the doses used, whereas this could be consistently achieved with the histamine H2-receptor antagonists, metiamide and cimetidine. In the group receiving these drugs only 1 patient out of 26 bled, compared with 13 (54%) of the controls, a highly significant difference. Blood-transfusion requirements were significantly less in those treated with H2-receptor antagonists.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Antacids / therapeutic use*
  • Clinical Trials as Topic
  • Drug Evaluation
  • Esophageal and Gastric Varices / prevention & control
  • Gastrointestinal Hemorrhage / epidemiology
  • Gastrointestinal Hemorrhage / mortality
  • Gastrointestinal Hemorrhage / prevention & control*
  • Guanidines / therapeutic use*
  • Hepatic Encephalopathy / complications*
  • Hepatic Encephalopathy / mortality
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Metiamide / therapeutic use
  • Peptic Ulcer Hemorrhage / prevention & control
  • Stomach Ulcer / complications
  • Stomach Ulcer / etiology

Substances

  • Antacids
  • Guanidines
  • Histamine H2 Antagonists
  • Imidazoles
  • Metiamide